BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27492555)

  • 1. Dual-time-point
    Huang YE; Huang YJ; Ko M; Hsu CC; Chen CF
    Ann Nucl Med; 2016 Nov; 30(9):652-658. PubMed ID: 27492555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited diagnostic value of Dual-Time-Point (18)F-FDG PET/CT imaging for classifying solitary pulmonary nodules in granuloma-endemic regions both at visual and quantitative analyses.
    Chen S; Li X; Chen M; Yin Y; Li N; Li Y
    Eur J Radiol; 2016 Oct; 85(10):1744-1749. PubMed ID: 27666611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-time point 18F-FDG PET/CT scan for differentiation between 18F-FDG-avid non-small cell lung cancer and benign lesions.
    Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
    Ann Nucl Med; 2009 Jul; 23(5):427-35. PubMed ID: 19437097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solitary pulmonary nodule evaluation in regions endemic for infectious diseases: Do regional variations impact the effectiveness of fluorodeoxyglucose positron emission tomography/computed tomography.
    Purandare NC; Pramesh CS; Agarwal JP; Agrawal A; Shah S; Prabhash K; Karimundackal G; Jiwnani S; Tandon S; Rangarajan V
    Indian J Cancer; 2017; 54(1):271-275. PubMed ID: 29199704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary clinical assessment of dynamic
    Shinya T; Otomi Y; Kubo M; Kinoshita M; Takechi K; Uyama N; Yamanaka M; Terazawa K; Toba H; Bando Y; Otsuka H; Harada M
    Ann Nucl Med; 2019 Jun; 33(6):414-423. PubMed ID: 30911883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical value of texture analysis of dual-time-point
    Nakajo M; Jinguji M; Aoki M; Tani A; Sato M; Yoshiura T
    Eur Radiol; 2020 Mar; 30(3):1759-1769. PubMed ID: 31728684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5.
    Chen CJ; Lee BF; Yao WJ; Cheng L; Wu PS; Chu CL; Chiu NT
    AJR Am J Roentgenol; 2008 Aug; 191(2):475-9. PubMed ID: 18647920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.
    Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R
    Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-time point
    Parghane RV; Basu S
    Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic role of dual-phase (18)F-FDG PET/CT in the characterization of solitary pulmonary nodules.
    Demir Y; Polack BD; Karaman C; Ozdoğan O; Sürücü E; Ayhan S; Akkoçlu A; Ozdemir N
    Nucl Med Commun; 2014 Mar; 35(3):260-7. PubMed ID: 24468852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of dual-time
    Pahk K; Chung JH; Kim S; Lee SH
    Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is
    Lee SH; Sung C; Lee HS; Yoon HY; Kim SJ; Oh JS; Song JW; Kim MY; Ryu JS
    Ann Nucl Med; 2018 Aug; 32(7):492-498. PubMed ID: 29974372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis to evaluate the diagnostic value of dual-time-point F-fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of pulmonary nodules.
    Zhao M; Ma Y; Yang B; Wang Y
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C304-C308. PubMed ID: 28230044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the diagnostic efficacy of
    Niyonkuru A; Chen X; Bakari KH; Wimalarathne DN; Bouhari A; Arnous MMR; Lan X
    Cancer Med; 2020 Feb; 9(3):931-942. PubMed ID: 31837121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of dual time point PET/CT for distinguishing malignant from benign focal 18F-FDG uptake duodenal lesions.
    Sa R; Zhao HG; Dai YY; Guan F
    Medicine (Baltimore); 2018 Sep; 97(38):e12521. PubMed ID: 30235771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ¹⁸F-FDG uptake features in the differential diagnosis of solitary pulmonary lesions with PET/CT.
    Zhao M; Chang B; Wei Z; Yu H; Tian R; Yuan L; Jin H
    World J Surg Oncol; 2015 Sep; 13():271. PubMed ID: 26369407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
    Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
    Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
    Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
    J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.